Achieve Life Sciences Inc (ACHV)
4.54
+0.04
(+0.89%)
USD |
NASDAQ |
Apr 24, 16:00
4.53
-0.01
(-0.22%)
After-Hours: 20:00
Achieve Life Sciences Cash from Financing (TTM): 15.28M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 15.28M |
September 30, 2023 | 32.99M |
June 30, 2023 | 33.12M |
March 31, 2023 | 19.27M |
December 31, 2022 | 19.32M |
September 30, 2022 | 16.53M |
June 30, 2022 | 16.41M |
March 31, 2022 | 36.47M |
December 31, 2021 | 36.61M |
September 30, 2021 | 37.62M |
June 30, 2021 | 52.23M |
March 31, 2021 | 32.96M |
December 31, 2020 | 32.68M |
September 30, 2020 | 29.44M |
June 30, 2020 | 14.82M |
March 31, 2020 | 17.28M |
December 31, 2019 | 17.32M |
September 30, 2019 | 9.632M |
June 30, 2019 | 10.48M |
March 31, 2019 | 18.65M |
December 31, 2018 | 19.76M |
September 30, 2018 | 15.64M |
June 30, 2018 | 15.88M |
March 31, 2018 | 3.086M |
December 31, 2017 | 2.001M |
Date | Value |
---|---|
September 30, 2017 | 1.257M |
June 30, 2017 | 0.17M |
March 31, 2017 | 0.17M |
December 31, 2016 | 0.15M |
September 30, 2016 | 0.014M |
June 30, 2016 | 14.43M |
March 31, 2016 | 17.64M |
December 31, 2015 | 17.59M |
September 30, 2015 | 17.59M |
June 30, 2015 | 22.34M |
March 31, 2015 | 25.16M |
December 31, 2014 | 25.25M |
September 30, 2014 | 25.23M |
June 30, 2014 | 6.064M |
March 31, 2014 | 0.03M |
December 31, 2013 | 0.01M |
September 30, 2013 | 0.012M |
June 30, 2013 | 0.358M |
March 31, 2013 | 0.47M |
December 31, 2012 | 54.24M |
September 30, 2012 | 54.24M |
June 30, 2012 | 54.02M |
March 31, 2012 | 53.91M |
December 31, 2011 | 0.219M |
September 30, 2011 | 47.02M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
9.632M
Minimum
Sep 2019
52.23M
Maximum
Jun 2021
25.29M
Average
19.32M
Median
Dec 2022
Cash from Financing (TTM) Benchmarks
Accelerate Diagnostics Inc | 9.019M |
ENDRA Life Sciences Inc | 7.518M |
Perspective Therapeutics Inc | 0.785M |
Electromed Inc | -0.128M |
Xtant Medical Holdings Inc | 19.69M |